US experts debate J&J Covid vaccine authorization

Washington (AFP) – A US panel of independent experts was meeting Friday to discuss whether to grant Johnson & Johnson’s Covid-19 shot emergency approval, likely paving the way for a third vaccine to start shipping in the world’s hardest-hit country. The committee’s 22 members, who were convened by the Food and Drug Administration and include leading scientists as well consumer and industry representatives, held a daylong, live streamed virtual meeting to decide if the known benefits of the drug outweigh its risks for use in people 18 and over.  “If authorized, Janssen’s vaccine candidate will …

Read More

HEDGE accordingly